Abstract  Nitrogen-containing bisphosphonates (N-BPs) conquer osteoclast-mediated pearl resorption and are widely utilised for tumor-associated
osteolysis. The execution of state of these drugs has not been completely clarified, but it has been observed that N-BPs
haw conquer squalene synthase or farnesyl pyrophosphate synthase. Zoledronic Elvis (ZA) represents a new N-BP which also
has antitumor activity. To explore the personalty of ZA on humour lipids, we unnatural 26 patients with angry myeloma at diagnosis.
Sixteen patients were aerated with ZA (4 mg) at line and at months 1, 2, 4, and 6. The remaining 10 served as controls.
In every subjects, amount cholesterin (TC), triglycerides (TGs), high-density lipoprotein cholesterin (HDL-C), low-density lipoprotein
cholesterin (LDL-C), and C-terminal telopeptide of identify I collagen (CTX) were rhythmic at line and after 1, 3, and 6 months.
In aerated patients, we observed a proportional and momentous change of TC, with a peak modification of 13% at 6 months.
Moreover LDL-C attenuated by 21% at 6 months, patch no momentous disagreement was understood in HDL-C and TGs. Also, the indexes
of cardiovascular venture reinforced after ZA administration: TC/HDL-C ratio progressively attenuated by 17% and HDL-C/LDL-C ratio
accumulated by 36%, display an gist that appears to be cumulative. In conclusion, ZA presented intravenously at broad doses in
patients with angry myeloma seems to be healthy to add the glyceride strikingness with an transformation of atherosclerotic risk
index.

Content Type Journal ArticleDOI 10.1007/s00223-008-9123-8Authors
Alessandro Gozzetti, University of Siena Division of Hematology and Transplants, Policlinico “Santa Maria Le Scotte” Siena 53100 ItalyLuigi Gennari, University of Siena Department of Internal Medicine Siena ItalyDaniela Merlotti, University of Siena Department of Internal Medicine Siena ItalyStefania Salvadori, University of Siena Department of Internal Medicine Siena ItalyVincenzo De Paola, University of Siena Department of Internal Medicine Siena ItalyAnnalisa Avanzati, University of Siena Department of Internal Medicine Siena ItalyBeatrice Franci, University of Siena Department of Internal Medicine Siena ItalyElena Marchini, University of Siena Division of Hematology and Transplants, Policlinico “Santa Maria Le Scotte” Siena 53100 ItalyMonica Tozzi, University of Siena Division of Hematology and Transplants, Policlinico “Santa Maria Le Scotte” Siena 53100 ItalyMaria painter Campagna, University of Siena Department of Internal Medicine Siena ItalyRanuccio Nuti, University of Siena Department of Internal Medicine Siena ItalyFrancesco Lauria, University of Siena Division of Hematology and Transplants, Policlinico “Santa Maria Le Scotte” Siena 53100 ItalyGiuseppe Martini, University of Siena Department of Internal Medicine Siena Italy

Journal Calcified Tissue InternationalOnline ISSN 1432-0827Print ISSN 0171-967X (Source: Calcified Tissue International)

Tags: cholesterol, Drugs, Led, lipid, Medicine, NCR, Risk, vascular